Herrera ID - Search Results

1

Smoking is associated with age at disease onset in Parkinson's disease.

Rosas I, Morís G, Coto E, Blázquez-Estrada M, Suárez E, García-Fernández C, Martínez C, Herrera ID, Pérez-Oliveira S, Álvarez V, Menéndez-González M; Spain_PD consortium. Rosas I, et al. Among authors: herrera id. Parkinsonism Relat Disord. 2022 Apr;97:79-83. doi: 10.1016/j.parkreldis.2022.03.005. Epub 2022 Mar 24. Parkinsonism Relat Disord. 2022. PMID: 35364453

2

[Isolation, sequencing and ultrastructure of HTLV-I and HTLV-II retroviruses. Presence of the HTLV-II subtype b among Spanish intravenous drug addicts].

Vallejo A, Casado C, Cantó C, Varela JM, Barge T, Rabella N, Herrera I, García Sáiz A. Vallejo A, et al. Med Clin (Barc). 1994 Dec 3;103(19):730-6. Med Clin (Barc). 1994. PMID: 7799679 Spanish.

3

Comparative study of different methods for measuring blood cyclosporine A levels in kidney transplantation.

Sabater J, Quereda C, Marcen R, Orofino L, Herrera I, Muñoz ML, Villafruela JJ, Ortuño J. Sabater J, et al. Transplant Proc. 1990 Aug;22(4):1720-2. Transplant Proc. 1990. PMID: 2202129 No abstract available.

4

[Effect of ciprofloxacin on the phagocytosis of Escherichia coli by human polymorphonuclear leukocytes].

Pérez P, Herrera I, Martín M, Gómez-Lus ML, Prieto J. Pérez P, et al. Enferm Infecc Microbiol Clin. 1993 Oct;11(8):411-4. Enferm Infecc Microbiol Clin. 1993. PMID: 8260511 Spanish.

5

Nonenzymatic glycosylation of hemoglobin and total plasmatic proteins in end-stage renal disease.

Sabater J, Quereda C, Herrera I, Pascual J, Villafruela JJ, Ortuño J. Sabater J, et al. Am J Nephrol. 1991;11(1):37-43. doi: 10.1159/000168270. Am J Nephrol. 1991. PMID: 2048577

6

Enhancement of the susceptibility of Staphylococcus aureus to phagocytosis after treatment with fosfomycin compared with other antimicrobial agents.

Pérez Fernández P, Herrera I, Martínez P, Gómez-Lus ML, Prieto J. Pérez Fernández P, et al. Chemotherapy. 1995 Jan-Feb;41(1):45-9. doi: 10.1159/000239323. Chemotherapy. 1995. PMID: 7875021

7

Enhanced susceptibility of Escherichia coli pretreated with RP7293 to leukocyte activity: comparison with other antimicrobial agents.

Pérez P, Herrera I, Martín M, Martínez P, Gómez-Lus ML. Pérez P, et al. Chemotherapy. 1994 Mar-Apr;40(2):99-103. doi: 10.1159/000239179. Chemotherapy. 1994. PMID: 8131640

8

Enhanced susceptibility of Staphylococcus aureus pretreated with cefepime and cefpodoxime to leukocyte activity.

Herrera I, Martinez P, Perez P, Garcia Y, Gomez-Lus ML, Prieto J. Herrera I, et al. J Chemother. 1995 Nov;7 Suppl 4:23-5. J Chemother. 1995. PMID: 8904094 No abstract available.

9

Rufloxacin enhances susceptibility of Escherichia coli to leukocyte activity.

Herrera I, Martinez P, Perez P, Martin M, Gomez-Lus ML, Prieto J. Herrera I, et al. J Chemother. 1995 Nov;7 Suppl 4:36-7. J Chemother. 1995. PMID: 8904099 No abstract available.

10

[Nodular cutaneous lesion in a homemaker].

Agustino AM, Maestre JM, Fernández-Valencia R, García J, Herrera I, Vivó A. Agustino AM, et al. Enferm Infecc Microbiol Clin. 2000 Oct;18(8):418-9. Enferm Infecc Microbiol Clin. 2000. PMID: 11153207 Spanish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page